Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Zhang, Zhong Wei ^a   Xu, Xiao Chao ^b   Liu, Ting ^c   Yuan, Shu ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b CHENGDU UNIVERSITY   (China)

^c Sichuan Langzhong Pharmaceutical Company Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; ASCORBIC ACID; NEURODEGENERATIVE DISEASES; PIGMENTS; VIRUSES;

AVIAN INFLUENZA; CARDIO-VASCULAR DISEASE; COMPARE AND ANALYZE; INFLAMMATORY RESPONSE; ISCHEMIA REPERFUSION; ORAL ADMINISTRATION; REACTIVE OXYGEN SPECIES; VIRUS INFECTION;

DISEASES;

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASTAXANTHIN; CAROTENOID; CYCLOSPORIN A; DOXORUBICIN; HYDROGEN PEROXIDE; IDEBENONE; NITRIC OXIDE; NORPHENAZONE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; S NITROSOGLUTATHIONE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ALZHEIMER DISEASE; APOPTOSIS; AVIAN INFLUENZA; BLEEDING; BRAIN ISCHEMIA; CARDIOTOXICITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG STRUCTURE; FATTY LIVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNOSURVEILLANCE; INFLUENZA A VIRUS (H1N1); INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MUSCLE CRAMP; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RASH; RESPIRATORY TRACT DISEASE; REVIEW; SEPSIS; VITAMIN K DEFICIENCY; ACUTE DISEASE; ANIMAL; DRUG EFFECTS; METABOLISM; MITOCHONDRION; ORAL DRUG ADMINISTRATION; PATHOLOGY; RESPIRATORY BURST;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

EID: 84949058189     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6859523     Document Type: Review

References (107)

1. H.-L. Hsieh and C.-M. Yang, "Role of redox signaling in neuroinflammation and neurodegenerative diseases, " BioMed Research International, vol. 2013, Article ID 484613, 18 pages, 2013.
2. S. Yuan, "Drugs to cure avian influenza infection-multiple ways to prevent cell death, " Cell Death and Disease, vol. 4, no. 10, article e835, 2013.
3. D. L. Carden and D. N. Granger, "Pathophysiology of ischaemia-reperfusion injury, " Journal of Pathology, vol. 190, no. 3, pp. 255-266, 2000.
4. R. K. Naviaux, "Oxidative shielding or oxidative stress?" The Journal of Pharmacology and Experimental Therapeutics, vol. 342, no. 3, pp. 608-618, 2012.
5. H. Y. Aboul-Enein, P. Berczýnski, and I. Kruk, "Phenolic compounds: The role of redox regulation in neurodegenerative disease and cancer, " Mini-Reviews in Medicinal Chemistry, vol. 13, no. 3, pp. 385-398, 2013.
6. C. Gorrini, I. S. Harris, and T.W. Mak, "Modulationof oxidative stress as an anticancer strategy, " Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931-947, 2013.
7. B. Jiang, S. Xiao, M. A. Khan, and M. Xue, "Defective antioxidant systems in cervical cancer, " Tumor Biology, vol. 34, no. 4, pp. 2003-2009, 2013.
8. Y. Kitagishi and S. Matsuda, "Redox regulation of tumor suppressor PTEN in cancer and aging (Review) , " International Journal of Molecular Medicine, vol. 31, no. 3, pp. 511-515, 2013.
9. M. Majzunova, I. Dovinova, M. Barancik, and J. Y. H. Chan, "Redox signaling in pathophysiology of hypertension, " Journal of Biomedical Science, vol. 20, no. 1, article 69, 2013.
10. R. Sgarbanti, D. Amatore, I. Celestino et al., "Intracellular redox state as target for anti-influenza therapy: Are antioxidants always effective?" Current Topics inMedicinal Chemistry, vol. 14, no. 22, pp. 2529-2541, 2014.
11. C. Villanueva and R. D. Kross, "Antioxidant-induced stress, " International Journal of Molecular Sciences, vol. 13, no. 2, pp. 2091-2109, 2012.
12. C. Nastos, K. Kalimeris, N. Papoutsidakis et al., "Global consequences of liver ischemia/reperfusion injury, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 906965, 13 pages, 2014.
13. Z.-W. Zhang, J. Cheng, F. Xu et al., "Mammal cells double their total RNAs against diabetes, ischemia reperfusion and malariainduced oxidative stress, " Molecular Medicine, vol. 17, no. 5-6, pp. 533-541, 2011.
14. M. C. W. Chan, C. Y. Cheung, W. H. Chui et al., "Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells, " Respiratory Research, vol. 6, article 135, 2005.
15. L. A. Perrone, J. K. Plowden, A. Garćia-Sastre, J. M. Katz, and T. M. Tumpey, "H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice, " PLoS Pathogens, vol. 4, no. 8, Article ID e1000115, 2008.
16. C. Cilloniz, M. J. Pantin-Jackwood, C. Ni et al., "Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection, " Journal of Virology, vol. 84, no. 15, pp. 7613-7624, 2010.
17. S. Fukuyama and Y. Kawaoka, "The pathogenesis of influenza virus infections: The contributions of virus and host factors, " CurrentOpinion in Immunology, vol. 23, no. 4, pp.481-486, 2011.
18. S. Tasaka, F. Amaya, S. Hashimoto, and A. Ishizaka, "Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome, " Antioxidants & Redox Signaling, vol. 10, no. 4, pp. 739-753, 2008.
19. K. R. Short, E. J. B. V. Kroeze, R. A.M. Fouchier, and T. Kuiken, "Pathogenesis of influenza-induced acute respiratory distress syndrome, " The Lancet Infectious Diseases, vol. 14, no. 1, pp. 57-69, 2014.
20. Y. Yamada, G. V. Limmon, D. Zheng et al., "Major shifts in the Spatio-Temporal distribution of lung antioxidant enzymes during influenza pneumonia, " PLoS ONE, vol. 7, no. 2, Article ID e31494, 2012.
21. M. Ueda, T. Daidoji, A. Du et al., "Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells, " Journal of Virology, vol. 84, no. 6, pp. 3068-3078, 2010.
22. C.P. Baines, R. A. Kaiser, N.H. Purcell et al., "Lossof cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death, " Nature, vol. 434, no. 7033, pp. 658-662, 2005.
23. D. Han, M. D. Ybanez, S. Ahmadi, K. Yeh, and N. Kaplowitz, "Redox regulation of tumor necrosis factor signaling, " Antioxidants and Redox Signaling, vol. 11, no. 9, pp. 2245-2263, 2009.
24. I. C. C. Low, J. Kang, and S. Pervaiz, "Bcl-2: A prime regulator of mitochondrial redox metabolism in cancer cells, " Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 2975-2987, 2011.
25. L. Pauling, Vitamin C and the Common Cold, Freeman Press, San Francisco, Calif, USA, 1970.
26. S. Lewin, VitaminC: ItsMolecular Biology andMedical Potential, Academic Press, New York, NY, USA, 1976.
27. J. S. Bland, Vitamin C: The Future is Now (Keats Good Health Guide) , McGraw-Hill Press, Columbus, Ohio, USA, 1998.
28. J. T. A. Ely, "Ascorbic acid role in containment of theworld avian flu pandemic, " Experimental Biology and Medicine, vol. 232, no. 7, pp. 847-851, 2007.
29. B. Antus and Z. Kardos, "Oxidative stress in COPD:molecular background and clinical monitoring, " CurrentMedicinal Chemistry, vol. 22, no. 5, pp. 627-650, 2015.
30. C. H. Wiegman, C. Michaeloudes, G. Haji et al., "Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease, " The Journal of Allergy and Clinical Immunology, 2015.
31. F. Q. Schafer and G. R. Buettner, "Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple, " Free Radical Biology & Medicine, vol. 30, no. 11, pp. 1191-1212, 2001.
32. J. M. Matés, C. Pérez-Gómez, I. N. De Castro, M. Asenjo, and J. Márquez, "Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death, " International Journal of Biochemistry&Cell Biology, vol. 34, no. 5, pp. 439-458, 2002.
33. T. Watanabe, M. Tahara, and S. Todo, "The novel antioxidant edaravone: from bench to bedside, " Cardiovascular Therapeutics, vol. 26, no. 2, pp. 101-114, 2008.
34. A. Hishida, "Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance, " Clinical and Experimental Nephrology, vol. 11, no. 4, pp. 292-296, 2007.
35. J. B. Schulz, N. A. Di Prospero, and K. Fischbeck, "Clinical experience with high-dose idebenone in Friedreich ataxia, " Journal of Neurology, vol. 256, no. 1, pp. 42-46, 2009.
36. H. Gutzmann, K.-P. Kühl, D. Hadler, and M. A. Rapp, "Safety and efficacy of idebenone versus tacrine in patients with Alzheimers disease: results of a randomized, double-blind, parallel-group multicenter study, " Pharmacopsychiatry, vol. 35, no. 1, pp. 12-18, 2002.
37. L. J. Thal, M. Grundman, J. Berg et al., "Idebenone treatment fails to slow cognitive decline in Alzheimers disease, " Neurology, vol. 61, no. 11, pp. 1498-1502, 2003.
38. T. Meier and G. Buyse, "Idebenone: An emerging therapy for Friedreich ataxia, " Journal of Neurology, vol. 256, supplement 1, pp. 25-30, 2009.
39. U. Singh and I. Jialal, "Alpha-lipoic acid supplementation and diabetes, " Nutrition Reviews, vol. 66, no. 11, pp. 646-657, 2008.
40. S. Tesfaye, "Advances in the management of diabetic peripheral neuropathy, " Current Opinion in Supportive and Palliative Care, vol. 3, no. 2, pp. 136-143, 2009.
41. S. Voutilainen, T. Nurmi, J. Mursu, and T. H. Rissanen, "Carotenoids and cardiovascular health, " The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1265-1271, 2006.
42. N. I. Krinsky and E. J. Johnson, "Carotenoid actions and their relation to health and disease, " Molecular Aspects of Medicine, vol. 26, no. 6, pp. 459-516, 2005.
43. S. K. Osganian, M. J. Stampfer, E. Rimm, D. Spiegelman, J. E. Manson, and W. C. Willett, "Dietary carotenoids and risk of coronary artery disease in women, " The American Journal of Clinical Nutrition, vol. 77, no. 6, pp. 1390-1399, 2003.
44. K. A. Huggins, K. J. Navara, M. T. Mendonça, and G. E. Hill, "Detrimental effects of carotenoid pigments: The dark side of bright coloration, " Naturwissenschaften, vol. 97, no. 7, pp. 637-644, 2010.
45. M. G. Traber, "Vitamin E regulatory mechanisms, " Annual Review of Nutrition, vol. 27, no. 1, pp. 347-362, 2007.
46. R. Siekmeier, C. Steffen, and W. März, "Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations, " Journal of Cardiovascular Pharmacology and Therapeutics, vol. 12, no. 4, pp. 265-282, 2007.
47. V. A. Kirsh, R. B. Hayes, S. T. Mayne et al., "Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk, " Journal of the National Cancer Institute, vol. 98, no. 4, pp. 245-254, 2006.
48. S. M. Lippman, E. A. Klein, P. J. Goodman et al., "Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , " The Journal of the American Medical Association, vol. 301, no. 1, pp. 39-51, 2009.
49. G. Dallner and P. J. Sindelar, "Regulation of ubiquinone metabolism, " Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 285-294, 2000.
50. U. Singh, S. Devaraj, and I. Jialal, "Coenzyme Q10 supplementation and heart failure, " Nutrition Reviews, vol. 65, no. 6, pp. 286-293, 2007.
51. P. S. Sandor, L. DiClemente, G. Coppola et al., "Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial, " Neurology, vol. 64, no. 4, pp. 71-75, 2005.
52. F. L. Rosenfeldt, S. J. Haas, H. Krum et al., "CoenzymeQ10 in the treatment of hypertension: Ameta-Analysis of the clinical trials, " Journal ofHumanHypertension, vol. 21, no. 4, pp. 297-306, 2007.
53. M. Mancuso, D. Orsucci, L. Volpi, V. Calsolaro, and G. Siciliano, "Coenzyme Q10 in neuromuscular and neurodegenerative disorders, " Current Drug Targets, vol. 11, no. 1, pp. 111-121, 2010.
54. G. F. Kelso, C. M. Porteous, C. V. Coulter et al., "Selective targeting of a redox-Active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties, " The Journal of Biological Chemistry, vol. 276, no. 7, pp. 4588-4596, 2001.
55. M. F. Ross, G. F. Kelso, F. H. Blaikie et al., "Lipophilic triphenylphosphoniumcations as tools inmitochondrial bioenergetics and free radical biology, " Biochemistry, vol. 70, no. 2, pp. 222-230, 2005.
56. R. A. J. Smith, R. C. Hartley, and M. P. Murphy, "Mitochondriatargeted small molecule therapeutics and probes, " Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 3021-3038, 2011.
57. E. J. Gane, F. Weilert, D. W. Orr et al., "The mitochondriatargeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients, " Liver International, vol. 30, no. 7, pp. 1019-1026, 2010.
58. B. J. Snow, F. L. Rolfe, M. M. Lockhart et al., "A doubleblind, placebo-controlled study to assess the mitochondriatargeted antioxidant MitoQ as a disease-modifying therapy in Parkinsons disease, " Movement Disorders, vol. 25, no. 11, pp. 1670-1674, 2010.
59. V. P. Skulachev, V. N. Anisimov, Y. N. Antonenko et al., "An attempt to prevent senescence: A mitochondrial approach, " Biochimica et Biophysica Acta, vol. 1787, no. 5, pp. 437-461, 2009.
60. B. M. Winklhofer-Roob, E. Rock, J. Ribalta, D. H. Shmerling, and J. M. Roob, "Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies, "Molecular Aspects ofMedicine, vol. 24, no. 6, pp. 391-402, 2003.
61. B. Capelli and G. Cysewski, ASTAXANTHIN Natural Astaxanthin: King of the Carotenoids, Cyanotech Corporation, Kailua, Hawaii, USA, 2007.
62. P. Cusack, N. McMeniman, A. Rabiee, and I. Lean, "Assessment of the effects of supplementation with vitamin E on health and production of feedlot cattle using meta-Analysis, " Preventive Veterinary Medicine, vol. 88, no. 4, pp. 229-246, 2009.
63. M. B. Lu, Y. E. Zhang, C. F. Zhao, P. P. Zhou, and L. J. Yu, "Analysis and identification of astaxanthin and its carotenoid precursors from Xanthophyllomyces dendrorhous by high-performance liquid chromatography, " Zeitschrift für Naturforschung, vol. 65, no. 7-8, pp. 489-494, 2010.
64. W. Wu, M. B. Lu, and L. J. Yu, "Expression of carotenogenic genes and astaxanthin production in Xanthophyllomyces dendrorhous as a function of oxygen tension, " Zeitschrift für Naturforschung, vol. 66, no. 5-6, pp. 283-286, 2011.
65. Y. Nishida, E. Yamashita, and W. Miki, "Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system, " Carotenoid Science, vol. 11, no. 6, pp. 16-20, 2007.
66. J. S. Park, H. W. Kim, B.D. Mathison et al., "Astaxanthin uptake in domestic dogs and cats, " Nutrition & Metabolism, vol. 7, no. 1, article 52, 2010.
67. R. G. Fassett and J. S. Coombes, "Astaxanthin, oxidative stress, inflammation and cardiovascular disease, " Future Cardiology, vol. 5, no. 4, pp. 333-342, 2009.
68. R. G. Fassett and J. S. Coombes, "Astaxanthin in cardiovascular health and disease, " Molecules, vol. 17, no. 2, pp. 2030-2048, 2012.
69. Y. Nakajima, Y. Inokuchi, M. Shimazawa, K. Otsubo, T. Ishibashi, and H. Hara, "Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo, " The Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1365-1374, 2008.
70. S. Piermarocchi, S. Saviano, V. Parisi et al., "Carotenoids in Agerelated Maculopathy Italian Study (CARMIS) : Two-year results of a randomized study, " European Journal ofOphthalmology, vol. 22, no. 2, pp. 216-225, 2012.
71. N. DOrazio, M. A. Gammone, E. Gemello, M. De Girolamo, S. Cusenza, and G. Riccioni, "Marine bioactives: pharmacological properties and potential applications against inflammatory diseases, " Marine Drugs, vol. 10, no. 4, pp. 812-833, 2012.
72. S.-J. Lee, S.-K. Bai, K.-S. Lee et al., "Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IB kinase-dependentNF-B activation, "Molecules and Cells, vol. 16, no. 1, pp. 97-105, 2003.
73. M. Ishiki, Y. Nishida, H. Ishibashi et al., "Impact of divergent effects of astaxanthin on insulin signaling in L6 cells, " Endocrinology, vol. 154, no. 8, pp. 2600-2612, 2013.
74. X. Song, B. Wang, S. Lin et al., "Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependentmitochondrial signalling pathway, " Journal of Cellular andMolecularMedicine, vol. 18, no. 11, pp. 2198-2212, 2014.
75. A. P. Bolin, R. C. Macedo, D. P. Marin, M. P. Barros, and R. Otton, "Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes, " Cell Biology and Toxicology, vol. 26, no. 5, pp. 457-467, 2010.
76. T. Tanaka, H. Makita, M. Ohnishi, H. Mori, K. Satoh, and A. Hara, "Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin, " Cancer Research, vol. 55, no. 18, pp. 4059-4064, 1995.
77. Y. Yasui, M. Hosokawa, N. Mikami, K. Miyashita, and T. Tanaka, "Dietary astaxanthin inhibits colitis and colitis-Associated colon carcinogenesis in mice via modulation of the inflammatory cytokines, " Chemico-Biological Interactions, vol. 193, no. 1, pp. 79-87, 2011.
78. T. Tanaka, M. Shnimizu, and H. Moriwaki, "Cancer chemoprevention by carotenoids, "Molecules, vol. 17, no. 3, pp. 3202-3242, 2012.
79. R. Nakao, O. L. Nelson, J. S. Park, B. D. Mathison, P. A. Thompson, and B. P. Chew, "Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice, " Anticancer Research, vol. 30, no. 6, pp. 2171-2175, 2010.
80. N. M. Lyons and N. M. OBrien, "Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture, " Journal of Dermatological Science, vol. 30, no. 1, pp. 73-84, 2002.
81. M. Santocono, M. Zurria, M. Berrettini, D. Fedeli, and G. Falcioni, "Lutein, zeaxanthin and astaxanthin protect against DNAdamage in SK-N-SHhuman neuroblastoma cells induced by reactive nitrogen species, " Journal of Photochemistry and Photobiology B: Biology, vol. 88, no. 1, pp. 1-10, 2007.
82. J.-P. Yuan, J. Peng, K. Yin, and J.-H. Wang, "Potential healthpromoting effects of astaxanthin: A high-value carotenoid mostly from microalgae, "Molecular Nutrition & Food Research, vol. 55, no. 1, pp. 150-165, 2011.
83. P. Kidd, "Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-Aging potential, " Alternative Medicine Review, vol. 16, no. 4, pp. 355-364, 2011.
84. P. Nagendraprabhu and G. Sudhandiran, "Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2, " Investigational New Drugs, vol. 29, no. 2, pp. 207-224, 2011.
85. P. Palozza, C. Torelli, A. Boninsegna et al., "Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells, " Cancer Letters, vol. 283, no. 1, pp. 108-117, 2009.
86. X.-D. Song, J.-J. Zhang, M.-R. Wang, W.-B. Liu, X.-B. Gu, and C.-J. Lv, "Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells, " Biological&Pharmaceutical Bulletin, vol. 34, no. 6, pp. 839-844, 2011.
87. X. Song, M. Wang, L. Zhang et al., "Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin, " ToxicologyMechanisms and Methods, vol. 22, no. 9, pp. 679-686, 2012.
88. H. McNulty, R. F. Jacob, and R. P. Mason, "Biologic activity of carotenoids related to distinct membrane physicochemical interactions, " The American Journal of Cardiology, vol. 101, no. 10, pp. S20-S29, 2008.
89. A. V. Kozlov, D. I. Egorov, I. A. Vladimirov, and O. A. Azizova, "Formation of iron complexes with ascorbic acid in physiological conditions in vitro and in tissue in vivo, " Biofizika, vol. 35, no. 3, pp. 513-517, 1990.
90. H.-S. Kim, M. J. Quon, and J.-A. Kim, "New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate, " Redox Biology, vol. 2, no. 1, pp. 187-195, 2014.
91. J. Choi, "Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations, " Free Radical Biology and Medicine, vol. 52, no. 7, pp. 1135-1150, 2012.
92. D. P. Vivekananthan, M. S. Penn, S. K. Sapp, A. Hsu, and E. J. Topol, "Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-Analysis of randomised trials, " The Lancet, vol. 361, no. 9374, pp. 2017-2023, 2003.
93. A. Shuaib, K. R. Lees, P. Lyden et al., "NXY-059 for the treatment of acute ischemic stroke, "The New England Journal ofMedicine, vol. 357, no. 6, pp. 562-571, 2007.
94. H. M. Cochemé and M. P. Murphy, "Can antioxidants be effective therapeutics?" Current Opinion in Investigational Drugs, vol. 11, no. 4, pp. 426-431, 2010.
95. O. Firuzi, R. Miri, M. Tavakkoli, and L. Saso, "Antioxidant therapy: current status and future prospects, " CurrentMedicinal Chemistry, vol. 18, no. 25, pp. 3871-3888, 2011.
96. J. D. Watson, "Type 2 diabetes as a redox disease, " The Lancet, vol. 383, no. 9919, pp. 841-843, 2014.
97. S. K. Powers and M. J. Jackson, "Exercise-induced oxidative stress: cellularmechanisms and impact onmuscle force production, " Physiological Reviews, vol. 88, no. 4, pp. 1243-1276, 2008.
98. M. Ristow, K. Zarse, A. Oberbach et al., "Antioxidants prevent health-promoting effects of physical exercise in humans, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665-8670, 2009.
99. A. Martin-Montalvo, E. M. Mercken, S. J. Mitchell et al., "Metformin improves health span and lifespan in mice, " Nature Communications, vol. 4, no. 1, p. 2192, 2013.
100. G. Nardai, K. Stadler, E. Papp, T. Korcsmáros, J. Jakus, and P. Csermely, "Diabetic changes in the redox status of the microsomal protein folding machinery, " Biochemical and Biophysical Research Communications, vol. 334, no. 3, pp. 787-795, 2005.
101. J. C. Smith, K. A. Nielson, P. Antuono et al., "Semanticmemory functional mri and cognitive function after exercise intervention in mild cognitive impairment, " Journal of Alzheimers Disease, vol. 37, no. 1, pp. 197-215, 2013.
102. A. Sujak, "Interactions between canthaxanthin and lipid membranes-possible mechanisms of canthaxanthin toxicity, " Cellular and Molecular Biology Letters, vol. 14, no. 3, pp. 395-410, 2009.
103. R. Goralczyk, "Beta-carotene and lung cancer in smokers: review of hypotheses and status of research, " Nutrition and Cancer, vol. 61, no. 6, pp. 767-774, 2009.
104. M.-F. Chen, C.-M. Yang, C.-M. Su, J.-W. Liao, and M.-L. Hu, "Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice, " Nutrition and Cancer, vol. 63, no. 7, pp. 1036-1043, 2011.
105. P. Chen, J. Stone, G. Sullivan, J. A. Drisko, and Q. Chen, "Anticancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models, " Free Radical Biology and Medicine, vol. 51, no. 3, pp. 681-687, 2011.
106. M. G. Traber and J. F. Stevens, "Vitamins C and E: beneficial effects fromamechanistic perspective, " Free Radical Biology and Medicine, vol. 51, no. 5, pp. 1000-1013, 2011.
107. N. J. White, R. G. Webster, E. A. Govorkova, and T.M. Uyeki, "What is the optimal therapy for patients with H5N1 influenza?" PLoS Medicine, vol. 6, no. 6, Article ID e1000091, 2009.